UK markets open in 5 hours 5 minutes

Foghorn Therapeutics Inc. (FHTX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.20+0.52 (+9.15%)
At close: 04:00PM EDT
6.20 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 314.27M
Enterprise value 150.58M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.06
Price/book (mrq)N/A
Enterprise value/revenue 4.44
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 3.15
52-week change 3-23.46%
S&P500 52-week change 324.69%
52-week high 39.97
52-week low 32.70
50-day moving average 36.09
200-day moving average 35.47

Share statistics

Avg vol (3-month) 388.32k
Avg vol (10-day) 3131.33k
Shares outstanding 555.33M
Implied shares outstanding 655.33M
Float 823.99M
% held by insiders 119.08%
% held by institutions 157.53%
Shares short (15 May 2024) 41.3M
Short ratio (15 May 2024) 417.8
Short % of float (15 May 2024) 44.47%
Short % of shares outstanding (15 May 2024) 43.05%
Shares short (prior month 15 Apr 2024) 41.18M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -274.23%
Operating margin (ttm)-558.30%

Management effectiveness

Return on assets (ttm)-20.46%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)33.9M
Revenue per share (ttm)0.81
Quarterly revenue growth (yoy)-4.90%
Gross profit (ttm)N/A
EBITDA -99.36M
Net income avi to common (ttm)-92.95M
Diluted EPS (ttm)-2.20
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)206.66M
Total cash per share (mrq)4.85
Total debt (mrq)42.98M
Total debt/equity (mrq)N/A
Current ratio (mrq)4.06
Book value per share (mrq)-2.29

Cash flow statement

Operating cash flow (ttm)-116.27M
Levered free cash flow (ttm)-52.85M